Patents by Inventor Phillip L. Stetson

Phillip L. Stetson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PON3 and uses thereof
    Patent number: 6916472
    Abstract: The present invention relates to paraoxonase genes, in particular PON3. The present invention provides isolated nucleotide sequence encoding PON3, wild type and mutant PON3 peptides. The present invention also provides methods for using PON3 to screen compounds for the ability to alter PON3 associated activities, methods for generating antibodies useful in the detection of PON3, and methods of treating and preventing oxidative damage, sepsis, chemical toxicity, and other conditions.
    Type: Grant
    Filed: June 27, 2002
    Date of Patent: July 12, 2005
    Assignee: Regents of the University of Michigan
    Inventors: Bert N. La Du, Dragomir I. Draganov, Phillip L. Stetson, Catherine E. Watson
  • PON3 and uses thereof
    Publication number: 20030144228
    Abstract: The present invention relates to paraoxonase genes, in particular PON3. The present invention provides isolated nucleotide sequence encoding PON3, wild type and mutant PON3 peptides. The present invention also provides methods for using PON3 to screen compounds for the ability to alter PON3 associated activities, methods for generating antibodies useful in the detection of PON3, and methods of treating and preventing oxidative damage, sepsis, chemical toxicity, and other conditions.
    Type: Application
    Filed: June 27, 2002
    Publication date: July 31, 2003
    Inventors: Bert N. La Du, Dragomir I. Draganov, Phillip L. Stetson, Catherine E. Watson
  • PON3 and uses thereof
    Patent number: 6573370
    Abstract: The present invention relates to paraoxonase genes, in particular PON3. The present invention provides isolated nucleotide sequence encoding PON3, wild type and mutant PON3 peptides. The present invention also provides methods for using PON3 to screen compounds for the ability to alter PON3 associated activities, methods for generating antibodies useful in the detection of PON3, and methods of treating and preventing oxidative damage, sepsis, chemical toxicity, and other conditions.
    Type: Grant
    Filed: May 19, 2000
    Date of Patent: June 3, 2003
    Assignee: Regents of the University of Michigan
    Inventors: Bert N. La Du, Dragomir I. Draganov, Phillip L. Stetson, Catherine E. Watson